Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Apr;114(8):1652–1656. doi: 10.1111/j.1476-5381.1995.tb14953.x

Inhibition of rabbit aortic smooth muscle cell proliferation by selective inhibitors of protein kinase C.

A C Newby 1, K Lim 1, M A Evans 1, N P Brindle 1, R F Booth 1
PMCID: PMC1510373  PMID: 7599935

Abstract

1. We studied the effect of two structurally-related, selective inhibitors of protein kinase C, Ro 31-8220 and Ro 31-7549, on the reinitiation of proliferation in quiescent first passage rabbit aortic smooth muscle cells in response to (a) the direct activator of protein kinase C, phorbol dibutyrate (PDBu), (b) platelet-derived growth factor (PDGF), (c) a combination of PDGF and 5-hydroxytryptamine (5-HT) or (d) serum. 2. Ro 31-8220 and Ro 31-7549 concentration-dependently inhibited proliferation in response to each mitogen. The inhibitory potency (IC50) of Ro 31-8220 and Ro 31-7549, respectively, was similar against proliferation induced by PDBu (0.55 and 1.1 microM), PDGF (0.6 and 0.9 microM), PDGF and 5-HT (0.68 and 1.1 microM), although slightly less against serum (1.7 and 5 microM). The effects of the protein kinase C inhibitors on proliferation could not be ascribed to cytotoxicity. Neither Ro 31-8220 nor Ro 31-7549 (0.3-3 microM) inhibited PDGF receptor tyrosine phosphorylation. 3. The results show that Ro 31-8220 and Ro 31-7549 are potent inhibitors of smooth muscle cell proliferation in response to a direct activator of protein kinase C, the defined growth factors, PDGF and 5-HT, and the complex mixture of mitogens in serum. Protein kinase C activation thus appears to be an important growth transducing mechanism for each of these agents.

Full text

PDF
1652

Images in this article

1655Figure 3
on p.1655

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angelini G. D., Newby A. C. The future of saphenous vein as a coronary artery bypass conduit. Eur Heart J. 1989 Mar;10(3):273–280. doi: 10.1093/oxfordjournals.eurheartj.a059476. [DOI] [PubMed] [Google Scholar]
  2. Araki S., Kawahara Y., Fukuzaki H., Takai Y. Serotonin plays a major role in serum-induced phospholipase C-mediated hydrolysis of phosphoinositides and DNA synthesis in vascular smooth muscle cells. Atherosclerosis. 1990 Jul;83(1):29–34. doi: 10.1016/0021-9150(90)90127-5. [DOI] [PubMed] [Google Scholar]
  3. Assender J. W., Southgate K. M., Hallett M. B., Newby A. C. Inhibition of proliferation, but not of Ca2+ mobilization, by cyclic AMP and GMP in rabbit aortic smooth-muscle cells. Biochem J. 1992 Dec 1;288(Pt 2):527–532. doi: 10.1042/bj2880527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brindle N. P., Tavare J. M., Dickens M., Whittaker J., Siddle K. Anti-(insulin receptor) monoclonal antibody-stimulated tyrosine phosphorylation in cells transfected with human insulin receptor cDNA. Biochem J. 1990 Jun 15;268(3):615–620. doi: 10.1042/bj2680615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davis P. D., Elliott L. H., Harris W., Hill C. H., Hurst S. A., Keech E., Kumar M. K., Lawton G., Nixon J. S., Wilkinson S. E. Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity. J Med Chem. 1992 Mar 20;35(6):994–1001. doi: 10.1021/jm00084a004. [DOI] [PubMed] [Google Scholar]
  6. Davis P. D., Hill C. H., Keech E., Lawton G., Nixon J. S., Sedgwick A. D., Wadsworth J., Westmacott D., Wilkinson S. E. Potent selective inhibitors of protein kinase C. FEBS Lett. 1989 Dec 18;259(1):61–63. doi: 10.1016/0014-5793(89)81494-2. [DOI] [PubMed] [Google Scholar]
  7. Egan S. E., Weinberg R. A. The pathway to signal achievement. Nature. 1993 Oct 28;365(6449):781–783. doi: 10.1038/365781a0. [DOI] [PubMed] [Google Scholar]
  8. Elliott L. H., Wilkinson S. E., Sedgwick A. D., Hill C. H., Lawton G., Davis P. D., Nixon J. S. K252a is a potent and selective inhibitor of phosphorylase kinase. Biochem Biophys Res Commun. 1990 Aug 31;171(1):148–154. doi: 10.1016/0006-291x(90)91369-4. [DOI] [PubMed] [Google Scholar]
  9. Graves L. M., Bornfeldt K. E., Raines E. W., Potts B. C., Macdonald S. G., Ross R., Krebs E. G. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10300–10304. doi: 10.1073/pnas.90.21.10300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. KISSANE J. M., ROBINS E. The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system. J Biol Chem. 1958 Jul;233(1):184–188. [PubMed] [Google Scholar]
  11. Kariya K. I., Kawahara Y., Tsuda T., Fukuzaki H., Takai Y. Possible involvement of protein kinase C in platelet-derived growth factor-stimulated DNA synthesis in vascular smooth muscle cells. Atherosclerosis. 1987 Feb;63(2-3):251–255. doi: 10.1016/0021-9150(87)90128-6. [DOI] [PubMed] [Google Scholar]
  12. Kariya K., Fukumoto Y., Tsuda T., Kawahara Y., Fukuzaki H., Yamamoto T., Takai Y. Inhibition of DNA synthesis by phorbol esters through protein kinase C in cultured rabbit aortic smooth muscle cells. FEBS Lett. 1987 Jun 8;217(1):69–73. doi: 10.1016/0014-5793(87)81245-0. [DOI] [PubMed] [Google Scholar]
  13. Kariya K., Kawahara Y., Fukuzaki H., Hagiwara M., Hidaka H., Fukumoto Y., Takai Y. Two types of protein kinase C with different functions in cultured rabbit aortic smooth muscle cells. Biochem Biophys Res Commun. 1989 Jun 30;161(3):1020–1027. doi: 10.1016/0006-291x(89)91345-4. [DOI] [PubMed] [Google Scholar]
  14. Khym J. X. An analytical system for rapid separation of tissue nucleotides at low pressures on conventional anion exchangers. Clin Chem. 1975 Aug;21(9):1245–1252. [PubMed] [Google Scholar]
  15. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  16. Matsumoto H., Sasaki Y. Staurosporine, a protein kinase C inhibitor interferes with proliferation of arterial smooth muscle cells. Biochem Biophys Res Commun. 1989 Jan 16;158(1):105–109. doi: 10.1016/s0006-291x(89)80183-4. [DOI] [PubMed] [Google Scholar]
  17. Meldrum E., Parker P. J., Carozzi A. The PtdIns-PLC superfamily and signal transduction. Biochim Biophys Acta. 1991 Mar 19;1092(1):49–71. doi: 10.1016/0167-4889(91)90177-y. [DOI] [PubMed] [Google Scholar]
  18. Muid R. E., Dale M. M., Davis P. D., Elliott L. H., Hill C. H., Kumar H., Lawton G., Twomey B. M., Wadsworth J., Wilkinson S. E. A novel conformationally restricted protein kinase C inhibitor, Ro 31-8425, inhibits human neutrophil superoxide generation by soluble, particulate and post-receptor stimuli. FEBS Lett. 1991 Nov 18;293(1-2):169–172. doi: 10.1016/0014-5793(91)81178-b. [DOI] [PubMed] [Google Scholar]
  19. Nemecek G. M., Coughlin S. R., Handley D. A., Moskowitz M. A. Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc Natl Acad Sci U S A. 1986 Feb;83(3):674–678. doi: 10.1073/pnas.83.3.674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nishizuka Y. Studies and perspectives of protein kinase C. Science. 1986 Jul 18;233(4761):305–312. doi: 10.1126/science.3014651. [DOI] [PubMed] [Google Scholar]
  21. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature. 1988 Aug 25;334(6184):661–665. doi: 10.1038/334661a0. [DOI] [PubMed] [Google Scholar]
  22. Ohmi K., Yamashita S., Nonomura Y. Effect of K252a, a protein kinase inhibitor, on the proliferation of vascular smooth muscle cells. Biochem Biophys Res Commun. 1990 Dec 31;173(3):976–981. doi: 10.1016/s0006-291x(05)80881-2. [DOI] [PubMed] [Google Scholar]
  23. Rhee S. G. Inositol phospholipids-specific phospholipase C: interaction of the gamma 1 isoform with tyrosine kinase. Trends Biochem Sci. 1991 Aug;16(8):297–301. doi: 10.1016/0968-0004(91)90122-c. [DOI] [PubMed] [Google Scholar]
  24. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993 Apr 29;362(6423):801–809. doi: 10.1038/362801a0. [DOI] [PubMed] [Google Scholar]
  25. Southgate K., Newby A. C. Serum-induced proliferation of rabbit aortic smooth muscle cells from the contractile state is inhibited by 8-Br-cAMP but not 8-Br-cGMP. Atherosclerosis. 1990 May;82(1-2):113–123. doi: 10.1016/0021-9150(90)90150-h. [DOI] [PubMed] [Google Scholar]
  26. Spielmann H., Jacob-Müller U., Schulz P. Simple assay of 0.1-1.0 pmol of ATP, ADP, and AMP in single somatic cells using purified luciferin luciferase. Anal Biochem. 1981 May 1;113(1):172–178. doi: 10.1016/0003-2697(81)90061-0. [DOI] [PubMed] [Google Scholar]
  27. Takagi Y., Hirata Y., Takata S., Yoshimi H., Fukuda Y., Fujita T., Hidaka H. Effects of protein kinase inhibitors on growth factor-stimulated DNA synthesis in cultured rat vascular smooth muscle cells. Atherosclerosis. 1988 Dec;74(3):227–230. doi: 10.1016/0021-9150(88)90241-9. [DOI] [PubMed] [Google Scholar]
  28. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991 Aug 25;266(24):15771–15781. [PubMed] [Google Scholar]
  29. Waller B. F., Pinkerton C. A., Orr C. M., Slack J. D., VanTassel J. W., Peters T. Restenosis 1 to 24 months after clinically successful coronary balloon angioplasty: a necropsy study of 20 patients. J Am Coll Cardiol. 1991 May;17(6 Suppl B):58B–70B. doi: 10.1016/0735-1097(91)90940-b. [DOI] [PubMed] [Google Scholar]
  30. Welsh G. I., Proud C. G. Evidence for a role for protein kinase C in the stimulation of protein synthesis by insulin in swiss 3T3 fibroblasts. FEBS Lett. 1993 Feb 1;316(3):241–246. doi: 10.1016/0014-5793(93)81300-o. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES